|
HS Code |
919247 |
| Iupac Name | (R)-(+)-alpha,alpha-Diphenyl-2-pyrrolidinemethanol |
| Cas Number | 127903-01-1 |
| Molecular Formula | C17H19NO |
| Molecular Weight | 253.34 g/mol |
| Appearance | White to off-white solid |
| Optical Rotation | +47° (c=1, MeOH) |
| Melting Point | 102-105°C |
| Solubility | Soluble in organic solvents such as methanol and dichloromethane |
| Purity | Typically >98% |
| Smiles | C1CC(NC1)C(O)(C2=CC=CC=C2)C3=CC=CC=C3 |
| Inchi | InChI=1S/C17H19NO/c19-17(15-10-6-2-7-11-15,16-12-8-3-9-13-16)14-18-15-5-1-4-14/h2-13,14,17,19H,1,4-5,14H2 |
As an accredited (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a 25-gram amber glass bottle, tightly sealed, with a white label displaying the compound name, quantity, and hazard warnings. |
| Shipping | (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol is carefully packaged in sealed, chemical-resistant containers to ensure stability during transit. The shipment complies with all relevant regulations for laboratory chemicals, includes appropriate labeling and documentation, and is typically dispatched via accredited couriers offering priority or temperature-controlled options when necessary for safe delivery. |
| Storage | (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol should be stored in a tightly sealed container, protected from light and moisture. Store at room temperature, in a cool, dry, well-ventilated area away from incompatible substances such as strong oxidizers. Proper labeling and secure placement are essential to prevent accidental exposure or contamination. Follow all relevant chemical safety and handling protocols. |
Applications of (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol in Industrial ManufacturingAs a specialized manufacturer of (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol, we supply this chiral intermediate to downstream industries where enantioselectivity and reliable process integration are essential. Extensive quality control and precise synthesis support its use in advanced applications. Below, we outline principal industrial sectors where our material serves as a key input—detailing relevant compliance frameworks, blending guidelines, role within each production process, and the resulting commercial products. 1. Pharmaceutical Intermediate for Chiral API SynthesisIn the pharmaceutical industry, our material acts as a critical chiral building block for synthesizing enantiomerically pure active pharmaceutical ingredients (APIs), including selective serotonin reuptake inhibitors and central nervous system agents. Controlled addition ensures the stereochemistry needed for target molecules, maintaining strict adherence to pharmacopoeial and GMP requirements throughout multistep flow or batch production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Synthesis of Chiral Ligands for CatalysisCatalyst manufacturers employ our material to synthesize chiral ligands required for enantioselective hydrogenation and cross-coupling reactions. Such ligands establish asymmetric induction in metal-catalyzed routes, supporting large-scale manufacture of high-value fine chemicals across several chemical sectors. Consistent ligand production hinges on the purity and precise enantiomeric excess of the sourced raw material. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Manufacture of Advanced Agrochemical IntermediatesProducers of high-activity agrochemicals rely on our chiral intermediate for constructing certain enantiopure active compounds, especially fungicides and insecticides where stereochemistry affects field performance. Trace-level contaminations or racemization affect downstream efficacy and regulatory acceptance, putting a premium on input molecule quality. Rigorous monitoring at batch and in-process stages ensures compliance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Production of Analytical Reagents for Chromatographic ResolutionManufacturers of chiral analytical reagents incorporate our material to develop stationary phase selectors and derivatizing agents for chromatographic enantiomer analysis. The demand for reproducibility in QC labs, especially in pharmaceuticals and food safety, drives the need for consistent stereochemical properties in the supplied raw material. Rigorous input controls minimize batch variation in final standards and columns. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Enantioselective Synthesis of Specialty ChemicalsIn R&D and pilot-scale specialty synthesis, our raw material is adopted for constructing fine chiral molecules used in chemical biology, advanced materials, and optical active auxiliaries. Industrial researchers value the precise enantiomeric control and consistent supply for iterative reaction optimization, particularly where performance and optical activity must meet design specifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a producer working daily with the development, optimization, and scaling of chiral molecules, I see (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol in action more than most. Years of refining batches, adjusting solvents, and repeating purifications convinced me long ago that the slightest difference in the stereochemistry of a reagent like this one can swing an entire synthesis toward success or setback. Let’s break that down for anyone evaluating materials for asymmetric synthesis, medicinal chemistry, or catalyst preparation.
We provide the (R)-enantiomer—this matters. Its absolute configuration opens tailored routes in asymmetric reactions and chiral auxiliaries. You can see the effect best in enantioselective reduction and addition processes, where unwanted byproducts quickly creep in if the molecule isn’t pure or if the wrong enantiomer is involved. Our facility’s control over the reaction conditions, the starting raw materials, and crystallization yields keep optical purity consistent across every batch. Scrupulous attention prevents batch-to-batch variability, which users in pharmaceutical R&D and scale-up labs deeply appreciate because it keeps their data and processes reproducible.
Batch records show that every lot of our (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol passes a chiral HPLC minimum of 99% enantiomeric excess, with residual solvent below analytical thresholds. Analytical chemists on the team run additional checks for heavy metals and trace byproducts. Keep in mind, these specifications grow out of hundreds of iterations in the plant—not abstract requirements or marketing descriptions. As far as physical state goes, our product appears as a crystalline solid, typically white to off-white depending on the minutiae of drying methods used. Melting point ranges show a slight shift based on atmospheric conditions, but process optimization has narrowed this range over the last few years through subtle tweaks in post-synthesis handling.
Choosing crystalline over amorphous forms also means more reliable handling during weighing and transfer. Clumping, static, or smearing impacts lab prep, and observations from teams using our material feed into continued improvement. Tactile feedback from bench chemists rarely makes it into published specifications, but in practice it plays a real role in the product’s daily use in both research batches and manufacturing runs. It’s details like this, coming from people with their sleeves rolled up, that keep a material fit for its actual working environment.
Most of our (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol goes toward asymmetric synthesis. Its pyrrolidine ring, with dual phenyls and the alcohol handle, gives catalytic scaffolding a reputation for straightforward induction of chirality in a wide variety of target compounds. Medicinal chemists reaching for this molecule count on it to serve both as an intermediate building block (especially for psychoactive and CNS-active scaffolds) and as a ligand in small-scale catalytic applications. Having produced and shipped this compound for years, I’ve watched it play a role as both an endpoint and a stepping-stone, shifting between these roles depending on chemistry trends in the academic and pharmaceutical world.
What draws process chemists to this compound is the handedness—it’s not just any pyrrolidinemethanol, but a specific orientation that interacts selectively within enzymes, or in metal-catalyzed transformations. Sourced with the wrong chirality, the compound may trigger a domino of failures down the development line: poor conversion, mixed product streams, extra purification steps, or outright regulatory hurdles if the target API’s required configuration goes missing. Our focus on stereochemistry isn’t academic; it’s demanded by regulations, and by the strict internal controls of scale-up teams worldwide.
There are other pyrrolidinemethanols on the market. Some buyers ask how ours stands out, and scientists on the process floor have a direct answer: robust handling, authentic chiral purity, and transparency during scale-up. Alchemizing these elements together in manufacturing only comes from day-in, day-out experience. For instance, the (S)-enantiomer will not substitute in applications keyed to the R-form. Occasionally a client compares us against racemic materials—here, they face the challenge of split product yields or laborious separation steps, both of which translate to time lost and extra cost. We minimize their risk with authentication at every lot transition. Our batch-to-batch analytical data is always available to support regulatory filings or quality assurance audits.
Process chemists notice subtleties, whether the compound stays free-flowing or cakes up under ambient humidity, whether shipment packaging keeps light and oxygen out. We respond by refining packaging with every bit as much attention as we give the synthesis itself. Fluctuations in global logistics forced us to try new solvent exchanges and drying techniques, not just to passively meet shelf-life projections but to practically extend real-world storage. These small, practical changes don’t feature in glossy catalogs, yet they arise from feedback cycles that only a hands-on producer can manage.
Years ago, procurement sometimes meant deciding between a handful of suppliers who shipped generic variants with traceability gaps. Production was run by the calendar, not by the end user’s needs. Today, quality standards driven by regulators, and by the high expectations of pharmaceutical, specialty, and fine chemistry clients, raise the bar constantly. Our operations grew up alongside green chemistry pressures—meaning less solvent waste, more renewable feedstock, and sectioned isolation of sensitive intermediates to reduce cross-contamination. Manufacturing practices evolve when we continuously re-invest in purification trains and solvent recovery, not just to meet but to anticipate compliance and environmental scrutiny.
The (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol leaving our site today reflects hundreds of small improvements: safer operator handling, lower energy input, and minimized waste. Practitioners pushing for greener routes find value in a product designed downstream to leave a smaller footprint at every stage. Where alternative sources bundle in hidden costs—impurities, extra filtration, uncertain provenance—our clients return because reliability offsets apparent savings from a cheaper, less carefully produced competitor. Years of regular audits by both internal teams and third-party assessors back up those claims. Certification isn’t a box-ticking exercise; it’s woven into the checkpoints from synthesis to shipment.
One overlooked factor when choosing a supplier is technology transfer: can the supplier provide you not just with a product, but with full history, traceability, and technical support? As the original manufacturer, we’re on the ground with every analytical certificate, method specification, and impurity profile. Transfer to contract manufacturing, or movement into GMP production environments, places unique demands that distributors or traders simply aren’t equipped to handle. For example, our technical documentation package can extend to include validation runs of analytical methods on both our own and external chromatographic systems.
Regulatory pressure, whether from European, American, or Asian agencies, obliges us to treat this molecule not as a commodity, but as a tightly controlled specialty reagent. We handle late-stage customization—say, special dried-down forms or custom packaging protocols—without disrupting the main production line. That flexibility, hard-earned, keeps drug pipeline projects moving without interruption. Speed counts, but depth of experience prevents short-cuts that endanger quality or compliance.
Producing (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol isn’t plug-and-play. Raw material purity, reaction kinetics, and workup protocols all invite careful supervision. Scale-up is not a matter of multiplying laboratory conditions; exothermic events, stirring rates, and even the geometry of reaction vessels factor in. My crew and I watch for signs—slight color changes, minute shifts in crystalline texture—that can signal a deviation, long before analytical equipment catches it. In the plant, tactile chemistry meets data-driven analytical support, and that balance keeps rejects rare.
Cost pressures are real, and commodity chemicals rise and fall with global feedstock markets. With years at the plant level, I’ve seen how forward planning on sourcing phenyl and pyrrolidine starting materials shields clients from price shocks and shortages. Our purchasing policies favor long-term sustainability and backup routes, driven by the lived lessons of previous supply squeezes. Resilience means keeping paths open and keeping clients informed, not just shipping what we have on hand in hopes that it will do.
Our QA isn’t limited to in-process checks. Beyond finished product analytics, we track stability under transport conditions, including variable humidity and temperature profiles. A pallet delayed on a hot tarmac can compromise a month’s work, so we run degradation studies and maintain relationships with logistics partners that understand chemical sensitivity. User-level feedback cycles into shipping process enhancements, so shipped solids retain traits seen when they leave our floor.
Packaging developments often come out of direct feedback: scientists in humid climates struggled with desiccant use or closure integrity, so we iterated packaging design to address those environmental realities. These adaptations aren’t always visible to procurement or QA officers, but in practice they shrink product loss and protect the integrity of high-value intermediates for our clients.
The line between small research samples and multi-kilogram development runs is more blurred than outsiders suspect. A research chemist may request a few grams to validate a synthetic route, only to ramp to kilo-scale within the quarter. We’re set up to provide consistent quality regardless of order size, with scale continuity built into both documentation and logistics. Chemists who start with our material at one stage report consistent behaviors and reactivity as their scale grows—a direct result of keeping all production in-house.
No two R&D projects are alike. Our technical support group has handled inquiries ranging from solubility under specific solvent gradients, to impurity identification in downstream processing. Lab staff aren’t reading from abstracts—they’re the very people synthesizing or handling the material daily, sharing practical tips earned through repetition. Scaling a novel synthesis route, bringing a startup project to pilot scale, or pivoting a synthetic target often requires adaptable support; we remain closely engaged, prioritizing responsiveness and technical detail over scripted responses.
Real improvements happen at the boundary where manufacturing meets application. Customer feedback—from multinational pharma to niche biotech start-ups—illuminates how even a change in bottling or an adjustment in drying can change usability. Ongoing collaboration with clients prompts modifications that ripple from the factory floor to end-user success, creating a cycle where the product improves through genuine engagement and transparency.
Our experience manufacturing (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol reinforces a belief: trust is built by tangible actions, not abstract promises or certifications. Many competitors outsource synthesis, or move between contract partners, creating hidden risk for the user. Our process sustains traceability from batch start to final delivery. Seeing the full journey from raw material to finished molecule, with each adjustment documented and justified, keeps the product consistent and reliable. This direct link to manufacture lets us stand behind every lot, ready with facts and a lived record, not just a certificate.
Materials produced in-house reflect a commitment rarely shared by buyers and resellers. There’s pride and accountability in watching a product persist through production, pass optimization hurdles, and reach client laboratories on time and to spec. Questions about crystal behavior, melting range shifts, or optical activity find answers rooted in familiarity: colleagues who’ve stood by the reactor, made the separation decisions, and seen the effect of real-world phenomena on yield and purity.
Scientists seeking reliable sources for chiral auxiliaries or fine chemicals benefit when the producer takes long view, continually investing in training, equipment, and analytical support. We’ve faced urgent challenges—unexpected regulatory hurdles, acute supply shortages, and new client requirements—and prevailed by leaning on our working knowledge and a steady improvement mindset. Each new production cycle serves as an opportunity to refine, offer direct technical support, and turn theoretical improvements into functional, client-centered solutions.
Every gram of (R)-(+)-Alpha,Alpha-Diphenyl-2-Pyrrolidinemethanol produced at our facility carries with it a legacy of focused process optimization, attention to real-world usability, and persistent engagement with customer needs. Lab, plant, and technical support teams stand ready to share the data, experience, and detailed knowledge behind every lot, making a dependable foundation for critical research, development, or manufacturing challenges. Our approach stems from years of hands-on refinement, reflecting product quality and supplier partnership clients continually rely on.